Comparison of Sugammadex (Org 25969) With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (P05960)

NCT00451217 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia, General

Interventions

DRUG: Sugammadex
DRUG: Neostigmine

Sponsor

Merck Sharp & Dohme LLC